IFNA1 and myeloproliferative disorder: First, one may speculate if smoking—exposing a huge systemic inflammatory load—may actually interfere with IFN signaling in MPN patients [176], implying either a weaker response to IFN-alpha2 or larger doses to be used to obtain adequate IFN responses in terms of inducing CHR.